Literature DB >> 32803639

Non-invasive stereotactic body radiation therapy for refractory ventricular arrhythmias: an institutional experience.

Robert Chin1, Justin Hayase2, Peng Hu3, Minsong Cao1, Jie Deng1, Olujimi Ajijola2, Duc Do2, Marmar Vaseghi2, Eric Buch2, Houman Khakpour2, Osamu Fujimura2, Yuliya Krokhaleva2, Carlos Macias2, Julie Sorg2, Jean Gima2, Geraldine Pavez2, Noel G Boyle2, Michael Steinberg1, Kalyanam Shivkumar2, Jason S Bradfield4.   

Abstract

BACKGROUND: Initial studies have reported excellent safety and efficacy for stereotactic body radiation therapy (SBRT) in patients with refractory ventricular tachycardia (VT).
METHODS: This is a single-center retrospective analysis of eight consecutive patients who underwent SBRT for refractory, scar-related VT. The anatomic target for radioablation was defined based on surface 12-lead ECG VT morphology, cardiac magnetic resonance imaging, and electroanatomic mapping data when available. The target volume treated and the prescribed radiation dose (15-25 Gy) was based on the combined clinical assessment of the cardiac electrophysiologist and radiation oncologist. Ventricular arrhythmias, radiation-related outcomes, and adverse events were monitored at follow-up.
RESULTS: Eight patients underwent nine SBRT sessions. All patients were male with an average age of 75 ± 7.3 years and mean ejection fraction of 21 ± 7%. SBRT was performed with delivery of an average of 22.2 ± 3.6 Gy in a single session with a procedure time of 18.2 ± 6.0 min. All but one session was performed on an inpatient basis. No acute complications occurred. During a median follow-up of 7.8 months (IQR 4.8, 9.9), ICD therapies decreased from median 69.5 (43.5, 115.8) pre-SBRT to 13.3 (IQR 7.7, 35.8) post-SBRT (p = 0.036). There were three patient deaths in the follow-up period, unrelated to SBRT. Apparent clinical benefit occurred 33% of the time after SBRT.
CONCLUSIONS: The patients experienced overall reduction in VT burden following SBRT, though not with the immediate effect seen in other patient series. Further studies (basic, translational, and clinical) are essential to determine the benefit of SBRT and if so, the optimal protocols and patient selection.
© 2020. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Ablation; Non-invasive; Stereotactic body radiation therapy; Ventricular tachycardia

Mesh:

Year:  2020        PMID: 32803639     DOI: 10.1007/s10840-020-00849-0

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  17 in total

1.  Stereotactic body radiation therapy: the report of AAPM Task Group 101.

Authors:  Stanley H Benedict; Kamil M Yenice; David Followill; James M Galvin; William Hinson; Brian Kavanagh; Paul Keall; Michael Lovelock; Sanford Meeks; Lech Papiez; Thomas Purdie; Ramaswamy Sadagopan; Michael C Schell; Bill Salter; David J Schlesinger; Almon S Shiu; Timothy Solberg; Danny Y Song; Volker Stieber; Robert Timmerman; Wolfgang A Tomé; Dirk Verellen; Lu Wang; Fang-Fang Yin
Journal:  Med Phys       Date:  2010-08       Impact factor: 4.071

2.  Stereotactic ablative radiotherapy for the treatment of refractory cardiac ventricular arrhythmia.

Authors:  Billy W Loo; Scott G Soltys; Lei Wang; Anthony Lo; Benjamin P Fahimian; Andrei Iagaru; Linda Norton; Xin Shan; Edward Gardner; Thomas Fogarty; Patrick Maguire; Amin Al-Ahmad; Paul Zei
Journal:  Circ Arrhythm Electrophysiol       Date:  2015-06

3.  Structural Interventions and Potential Unforeseen Limits on Access to Ventricular Tachycardia Substrates.

Authors:  Evangelos Diamantakos; Reed Harvey; Kalyanam Shivkumar; Jason S Bradfield
Journal:  JACC Clin Electrophysiol       Date:  2019-08-19

4.  Stereotactic radiosurgery for ablation of ventricular tachycardia.

Authors:  Radek Neuwirth; Jakub Cvek; Lukas Knybel; Otakar Jiravsky; Lukas Molenda; Michal Kodaj; Martin Fiala; Petr Peichl; David Feltl; Jaroslav Januška; Jan Hecko; Josef Kautzner
Journal:  Europace       Date:  2019-07-01       Impact factor: 5.214

5.  Phase I/II Trial of Electrophysiology-Guided Noninvasive Cardiac Radioablation for Ventricular Tachycardia.

Authors:  Clifford G Robinson; Pamela P Samson; Kaitlin M S Moore; Geoffrey D Hugo; Nels Knutson; Sasa Mutic; S Murty Goddu; Adam Lang; Daniel H Cooper; Mitchell Faddis; Amit Noheria; Timothy W Smith; Pamela K Woodard; Robert J Gropler; Dennis E Hallahan; Yoram Rudy; Phillip S Cuculich
Journal:  Circulation       Date:  2019-01-15       Impact factor: 29.690

Review 6.  2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.

Authors:  Sana M Al-Khatib; William G Stevenson; Michael J Ackerman; William J Bryant; David J Callans; Anne B Curtis; Barbara J Deal; Timm Dickfeld; Michael E Field; Gregg C Fonarow; Anne M Gillis; Christopher B Granger; Stephen C Hammill; Mark A Hlatky; José A Joglar; G Neal Kay; Daniel D Matlock; Robert J Myerburg; Richard L Page
Journal:  J Am Coll Cardiol       Date:  2017-10-30       Impact factor: 24.094

7.  Noninvasive Cardiac Radiation for Ablation of Ventricular Tachycardia.

Authors:  Phillip S Cuculich; Matthew R Schill; Rojano Kashani; Sasa Mutic; Adam Lang; Daniel Cooper; Mitchell Faddis; Marye Gleva; Amit Noheria; Timothy W Smith; Dennis Hallahan; Yoram Rudy; Clifford G Robinson
Journal:  N Engl J Med       Date:  2017-12-14       Impact factor: 91.245

8.  Rescue procedure for an electrical storm using robotic non-invasive cardiac radio-ablation.

Authors:  Raphaël Jumeau; Mahmut Ozsahin; Juerg Schwitter; Véronique Vallet; Frédéric Duclos; Michele Zeverino; Raphaël Moeckli; Etienne Pruvot; Jean Bourhis
Journal:  Radiother Oncol       Date:  2018-05-09       Impact factor: 6.280

9.  Improved late gadolinium enhancement MR imaging for patients with implanted cardiac devices.

Authors:  Shams Rashid; Stanislas Rapacchi; Marmar Vaseghi; Roderick Tung; Kalyanam Shivkumar; J Paul Finn; Peng Hu
Journal:  Radiology       Date:  2013-10-28       Impact factor: 11.105

10.  Risen from the dead: Cardiac stereotactic ablative radiotherapy as last rescue in a patient with refractory ventricular fibrillation storm.

Authors:  Eberhard P Scholz; Katharina Seidensaal; Patrick Naumann; Florian André; Hugo A Katus; Jürgen Debus
Journal:  HeartRhythm Case Rep       Date:  2019-03-21
View more
  12 in total

Review 1.  Stereotactic radioablation for ventricular tachycardia.

Authors:  Stephan Hohmann; Henrike A K Hillmann; Johanna Müller-Leisse; Jörg Eiringhaus; Christos Zormpas; Roland Merten; Christian Veltmann; David Duncker
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2021-11-26

2.  Safety and Efficacy of Stereotactic Arrhythmia Radioablation for the Treatment of Ventricular Tachycardia: A Systematic Review.

Authors:  Giovanni Volpato; Paolo Compagnucci; Laura Cipolletta; Quintino Parisi; Yari Valeri; Laura Carboni; Andrea Giovagnoni; Antonio Dello Russo; Michela Casella
Journal:  Front Cardiovasc Med       Date:  2022-08-22

3.  Impact of High-Dose Irradiation on Human iPSC-Derived Cardiomyocytes Using Multi-Electrode Arrays: Implications for the Antiarrhythmic Effects of Cardiac Radioablation.

Authors:  Jae Sik Kim; Seong Woo Choi; Yun-Gwi Park; Sung Joon Kim; Chang Heon Choi; Myung-Jin Cha; Ji Hyun Chang
Journal:  Int J Mol Sci       Date:  2021-12-29       Impact factor: 5.923

4.  Computational ECG mapping and respiratory gating to optimize stereotactic ablative radiotherapy workflow for refractory ventricular tachycardia.

Authors:  Gordon Ho; Todd F Atwood; Andrew R Bruggeman; Kevin L Moore; Elliot McVeigh; Christopher T Villongco; Frederick T Han; Jonathan C Hsu; Kurt S Hoffmayer; Farshad Raissi; Grace Y Lin; Amir Schricker; Christopher E Woods; Joey P Cheung; Al V Taira; Andrew McCulloch; Ulrika Birgersdotter-Green; Gregory K Feld; Arno J Mundt; David E Krummen
Journal:  Heart Rhythm O2       Date:  2021-09-20

5.  Non-invasive Stereotactic Body Radiation Therapy for Refractory Ventricular Arrhythmias: Venturing into the Unknown.

Authors:  Justin Hayase; Robert Chin; Minsong Cao; Peng Hu; Kalyanam Shivkumar; Jason S Bradfield
Journal:  J Innov Card Rhythm Manag       Date:  2022-02-15

6.  Surgical ablation after stereotactic body radiation therapy for ventricular arrhythmias.

Authors:  Justin Hayase; Robert Chin; Murray Kwon; Minsong Cao; Peng Hu; Olujimi Ajijola; Noel Boyle; Kalyanam Shivkumar; Jason S Bradfield
Journal:  HeartRhythm Case Rep       Date:  2021-11-03

7.  Case Report: Repeated Stereotactic Radiotherapy of Recurrent Ventricular Tachycardia: Reasons, Feasibility, and Safety.

Authors:  Jana Haskova; Petr Peichl; Marek Šramko; Jakub Cvek; Lukáš Knybel; Otakar Jiravský; Radek Neuwirth; Josef Kautzner
Journal:  Front Cardiovasc Med       Date:  2022-03-28

8.  Long Term Follow-Up of Stereotactic Body Radiation Therapy for Refractory Ventricular Tachycardia in Advanced Heart Failure Patients.

Authors:  John Wight; Thomas Bigham; Arielle Schwartz; Arslan T Zahid; Neal Bhatia; Soroosh Kiani; Anand Shah; Stacy Westerman; Kristin Higgins; Michael S Lloyd
Journal:  Front Cardiovasc Med       Date:  2022-04-29

Review 9.  Stereotactic Radiotherapy: An Alternative Option for Refractory Ventricular Tachycardia to Drug and Ablation Therapy.

Authors:  Wenfeng Shangguan; Gang Xu; Xin Wang; Nan Zhang; Xingpeng Liu; Guangping Li; Gary Tse; Tong Liu
Journal:  J Clin Med       Date:  2022-06-20       Impact factor: 4.964

10.  Histopathological Examination of an Explanted Heart in a Long-Term Responder to Cardiac Stereotactic Body Radiotherapy (STereotactic Arrhythmia Radioablation).

Authors:  Marcin Miszczyk; Mateusz Sajdok; Jerzy Nożyński; Magdalena Cybulska; Jacek Bednarek; Tomasz Jadczyk; Tomasz Latusek; Radoslaw Kurzelowski; Łukasz Dolla; Wojciech Wojakowski; Agnieszka Dyla; Michał Zembala; Anna Drzewiecka; Konrad Kaminiów; Anna Kozub; Ewa Chmielik; Aleksandra Grza Dziel; Adam Bekman; Krzysztof Stanisław Gołba; Sławomir Blamek
Journal:  Front Cardiovasc Med       Date:  2022-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.